(Q43888726)

English

In-vitro and in-vivo pharmacokinetic interactions of amprenavir, an HIV protease inhibitor, with other current HIV protease inhibitors in rats

scientific article published in February 2002

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

In-vitro and in-vivo pharmacokinetic interactions of amprenavir, an HIV protease inhibitor, with other current HIV protease inhibitors in rats (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

Nobuhito Shibata

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Weihua Gao

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Hiroyuki Okamoto

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Tomoyuki Kishida

4

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Yukako Yoshikawa

5

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Kanji Takada

6

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

publication date

1 February 2002

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Journal of Pharmacy and Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

54

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

221-229

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Protease inhibitors in patients with HIV disease. Clinically important pharmacokinetic considerations

1 reference

https://api.crossref.org/works/10.1211%2F0022357021778411

21 January 2018

The effect of plasma drug concentrations on HIV-1 clearance rate during quadruple drug therapy

1 reference

https://api.crossref.org/works/10.1211%2F0022357021778411

21 January 2018

Ordered accumulation of mutations in HIV protease confers resistance to ritonavir

1 reference

https://api.crossref.org/works/10.1211%2F0022357021778411

21 January 2018

Saquinavir. A review of its pharmacology and clinical potential in the management of HIV infection

1 reference

https://api.crossref.org/works/10.1211%2F0022357021778411

21 January 2018

Membrane interactions of some catamphiphilic drugs and relation to their multidrug-resistance-reversing ability.

1 reference

https://api.crossref.org/works/10.1211%2F0022357021778411

21 January 2018

Effect of saquinavir on the pharmacokinetics and pharmacodynamics of oral and intravenous midazolam.

1 reference

https://api.crossref.org/works/10.1211%2F0022357021778411

21 January 2018

Pharmacokinetic interactions between HIV-1 protease inhibitors in rats: study on combinations of two kinds of HIV-1 protease inhibitors

1 reference

https://api.crossref.org/works/10.1211%2F0022357021778411

21 January 2018

Active apical secretory efflux of the HIV protease inhibitors saquinavir and ritonavir in Caco-2 cell monolayers

1 reference

https://api.crossref.org/works/10.1211%2F0022357021778411

21 January 2018

Hepatic and intestinal metabolism of indinavir, an HIV protease inhibitor, in rat and human microsomes. Major role of CYP3A

1 reference

https://api.crossref.org/works/10.1211%2F0022357021778411

21 January 2018

Modulation of P-glycoprotein function in human lymphocytes and Caco-2 cell monolayers by HIV-1 protease inhibitors.

1 reference

https://api.crossref.org/works/10.1211%2F0022357021778411

21 January 2018

Protease inhibitors as inhibitors of human cytochromes P450: high risk associated with ritonavir

1 reference

https://api.crossref.org/works/10.1211%2F0022357021778411

21 January 2018

Oral absorption of the HIV protease inhibitors: a current update

1 reference

https://api.crossref.org/works/10.1211%2F0022357021778411

21 January 2018

Pharmacokinetic interactions between HIV-protease inhibitors in rats

1 reference

https://api.crossref.org/works/10.1211%2F0022357021778411

21 January 2018

Identifiers

10.1211/0022357021778411

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43888726&oldid=2143722858"